| Naam | Eortc Cancer Research Fund |
|---|---|
| Website | https://www.eortc.org |
| Socials |
For more than 60 years, EORTC has pursued a simple mission: improving the lives of people with cancer through independent, international research. This World Cancer Day, we reflect on what that mission has delivered in...
A large multinational clinical trial has found that giving healthcare providers access to European Organisation for Research and Treatment of Cancer (EORTC) patient-reported outcome (PRO) data significantly improves the...
EORTC is pleased to announce the activation of the first site for the VIGOR study (EORTC-2427-BTG), a pivotal Phase III trial evaluating vorasidenib as maintenance treatment following completion of first-line chemoradio...
EORTC, together with the European Medicines Agency (EMA), and in collaboration with key stakeholders have published a multistakeholder roadmap outlining strategic actions to advance treatment optimisation research in on...
An important study by Sam Sodergren et al.1, detailing the development of a new Health-Related Quality of Life (HRQoL) questionnaire for adolescents and young adults with cancer, was published online in JAMA Network Ope...
Brussels, 19 December 2025 On 9 December, EORTC hosted the second P-value Workshop, and welcomed over 250 participants online from over 43 countries. The workshop, marking 100 years of the 5% p-value cutoff, was a great...
Brussels, 25 November 2025 - The SISAQOL-IMI consortium, co-led by the European Organisation for Research and Treatment of Cancer (EORTC) and Boehringer Ingelheim (BI), funded with an IMI2 grant, just announced the publ...
The European Organisation for Research and Treatment of Cancer (EORTC) is proud to participate in ISPOR Europe 2025, the leading global conference on health economics and outcomes research (HEOR), taking place from 9 to...
The European Organisation for Research and Treatment of Cancer (EORTC) is proud to announce its participation as a Gold Sponsor at the International Society for Quality of Life Research (ISOQOL) 2025 Annual Conference,...
Important new results and future trials were reported at the 2025 ESMO Congress held in Berlin from 17-21 October, further underlining the extent of EORTC’s commitment to innovative, independent cancer research. What ha...
